The demand for ultrasound has outpaced the supply of trained sonographers over the past 15 years, straining hospital ...
March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...
March 10, 2026 — HeartHero has announced that its Premarket Approval (PMA) application for Elliot, the company’s ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
March 6, 2026 — Building on its leadership in cardiac MR, Philips has received FDA 510(k) clearance for SmartHeart, an ...
March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...
March 2, 2026 — Ascend Cardiovascular has launched its re-imagined pediatric cardiology product, a comprehensive ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 4, 2026 — Inflo Health has launched a comprehensive cardiology suite designed to address care management gaps ...
March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...
March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
March 3, 2026 — MedDream will present its cloud-native, AI-ready universal DICOM viewer in the Amazon Web Services (AWS) ...
Feb. 27, 2026 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s CardioMEMS Hero device — a pulmonary ...
Feb. 25, 2026 — Gentuity LLC, a medical technology company specializing in next-generation intravascular imaging devices ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Feb. 26, 2026 — Eko Health has partnered with Wayne General Hospital in Wayne County, Mississippi, to deploy SENSORA, an ...
Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...
Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...
March 11, 2026
